Topical Absorbable Hemostats Market Report 2025

The topical absorbable hemostats market size has grown strongly in recent years. It will grow from $2.02 billion in 2024 to $2.17 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to an increasing demand for accelerated wound healing, expansion of ambulatory surgical centers, heightened emphasis on surgical safety and outcomes, greater adoption in dental and orthopedic procedures, and a rise in elective surgeries.

The topical absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 7%. The anticipated growth in the forecast period can be attributed to the increasing volume of surgical procedures, a rise in trauma and accident cases, an expanding elderly population, growth in minimally invasive surgeries, and a higher incidence of bleeding disorders. Key trends expected during this period include innovations in hemostatic technologies, a broader variety of product types, development of biodegradable and biocompatible materials, technological integration within surgical devices, and the inclusion of hemostats in surgical kits.

The growing number of surgical procedures is expected to drive the expansion of the topical absorbable hemostats market. Surgical procedures involve medically performed operations that include incisions or manipulation of body tissues to diagnose, treat, or improve health conditions. This rise in surgeries is mainly attributed to the increasing aging population, as older adults are more prone to chronic diseases and degenerative conditions that often require surgical intervention. Topical absorbable hemostats are beneficial during surgeries because they quickly control bleeding and do not need to be removed, which helps reduce operation time and lowers the risk of complications. For example, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based professional organization, reported that aesthetic procedures reached nearly 35 million in 2023, with total surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Thus, the rising volume of surgical procedures is contributing to the growth of the topical absorbable hemostats market.

Key players in the topical absorbable hemostats market are focusing on developing innovative products such as absorbable hemostatic powders to better control bleeding in complex or irregular wound areas. These powders are preferred because they provide rapid bleeding control without needing removal, which reduces infection risks and simplifies post-operative care. For instance, in July 2023, Baxter International, a US-based healthcare company, introduced PERCLOT, an absorbable hemostatic powder. PERCLOT provides surgeons with a comprehensive range of active and passive hemostatic solutions to ensure effective bleeding management. Its specially designed granules absorb moisture almost immediately, forming an adhesive gel that physically seals tissue surfaces. This gel concentrates platelets, red blood cells, and clotting factors like thrombin and fibrinogen, speeding up the body’s natural coagulation process. Reliable control of diverse intraoperative bleeding using PERCLOT can reduce transfusion needs, prevent major complications, and ultimately lower overall treatment costs.

In May 2023, Cousin Surgery, a France-based supplier of implantable medical devices, acquired PlantTec Medical for an undisclosed amount. This acquisition allows Cousin Surgery to broaden its cross-selling opportunities and enhance its research and development capabilities. It also adds a team with specialized expertise in surgical medical devices, strengthening the company’s presence in the German market. PlantTec Medical is a Germany-based manufacturer of topical absorbable hemostats.

Major players in the topical absorbable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Advanced Medical Solutions Group Plc, 3D Matrix Ltd., Advanced Biotech Products Pvt. Ltd., Curasan AG, Hemostasis LLC, Advamedica Inc., Medcura Inc., Endomedix Incorporated, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Cura Medical BV, and ETX Pharma Inc.

North America was the largest region in the topical absorbable hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in topical absorbable hemostats report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the topical absorbable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical absorbable hemostats market consists of sales of flowable gelatin matrix agents, bioabsorbable composite hemostatic dressings, and dual-component hemostatic kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The topical absorbable hemostats market research report is one of a series of new reports that provides topical absorbable hemostats market statistics, including topical absorbable hemostats industry global market size, regional shares, competitors with a topical absorbable hemostats market share, detailed topical absorbable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the topical absorbable hemostats industry. This topical absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Topical absorbable hemostats are specialized medical products designed to aid the body’s natural blood clotting during surgical procedures or traumatic bleeding. These agents are applied directly to bleeding areas and are formulated to be gradually broken down and absorbed by the body, eliminating the need for surgical removal.

The primary categories of topical absorbable hemostats include gelatin-based, collagen-based, fibrin-based, cellulose-based, and other types. Gelatin-based hemostats are derived from purified animal gelatin, typically sourced from pigs or cows. They are delivered through various forms such as surgical sprays, pads and gauzes, foams and films, and injectable solutions. These hemostats find applications in orthopedic, cardiothoracic, general, neurological, urological, and gynecological surgeries. Their main users include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.